Who owns science? Who funds science?

Grim realities that will have to be confronted as the “IP waiver” proposal, put forward by India and South Africa, gets discussed at the highest level at the World Trade Organization.

In this week's episode of the pulse podcast, Leena Menghaney, South Asia Head, MSF (Médecins Sans Frontières) Access Campaign, helps breakdown the complex maze of intellectual property rights (IPR), funding of research, and the final impact on access to medicines, vaccines, diagnostics, and other medical tools, during the pandemic and beyond.

Listen in.